As a prognostic indicator of unfavorable outcomes in osteosarcoma and a universal marker for immune infiltration across various cancers, MYBL2 exerts regulatory control over proliferation, tumor advancement, and immune cell infiltration within osteosarcoma and broader cancer contexts (47). The gene discussed is MYBL2; the disease is cancer.